Miltefosine and GM-CSF in Cutaneous Leishmaniasis

NCT03023111 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Leishmaniasis

Interventions

DRUG: Sbv
DRUG: Miltefosine plus placebo
DRUG: Miltefosine plus GM-CSF

Sponsor

Hospital Universitário Professor Edgard Santos

Collaborators

[object Object]